Market Tracker

11/21 4:12pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

2.88
Delayed Data
As of 3:57pm ET
 +0.08 / +2.86%
Today’s Change
1.93
Today|||52-Week Range
3.55
+35.85%
Year-to-Date
9 Positions Charles Brandes Increased in the Past 2 Quarters
Nov 15 / GuruFocus News - Paid Partner Content
Puma (PBYI) Falls Despite Narrower-Than-Expected Q3 Loss
Nov 10 / Zacks.com - Paid Partner Content
AstraZeneca Gets Positive CHMP Opinion for Asthma Candidate
Nov 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.80
Today’s open2.80
Day’s range2.79 - 2.88
Volume2,102,806
Average volume (3 months)1,918,545
Market cap$432.1M
Dividend yield--
Data as of 3:57pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-80.79%
Earnings growth (this year)+66.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-59.03%
P/E ratio5.8
Price/Sales1.45
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...-0.15-1.02%
NKNantKwest Inc+0.08+1.55%
SYRSSyros Pharmaceutical...+0.51+3.95%
CYADCelyad SA-1.31-2.87%
Data as of 3:57pm ET, 11/21/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)$0.11
Annual revenue (last year)$239.7M
Annual profit (last year)$63.6M
Net profit margin26.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John Peter McLaughlin
President
Dominique Monnet
Corporate headquarters
Incline Village, Nevada

Forecasts